Changes to the website
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4924

Next 25
Website Changes
01/19/2017 Musella Foundation Copayment Assistance Program is now closed to new patients
01/19/2017 Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
01/19/2017 New Study Aims to Extend TTFields Beyond Grade IV Brain Cancer Domain
01/19/2017 Glioblastoma Treatment Breakthrough: `Untreatable` Brain Cancer Tumor Stabilized With Malaria Drug
01/19/2017 Novocure’s Optune® Now Available at 500 Cancer Treatment Centers in the U.S.
01/15/2017 Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.
01/14/2017 National Walk To End Brain Tumors – Volunteers needed
01/13/2017 Salmonella Has Been Genetically Engineered to Consume Brain Tumors
01/03/2017 Musella Foundation Copay Assistance Program reopens!
12/31/2016 Florescent light helps surgeons target brain tumors
12/31/2016 Pathway linked to slower aging also fuels brain cancer
12/31/2016 Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
12/31/2016 A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastomas.
12/31/2016 Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization.
12/31/2016 Top Brain Tumor News Stories for 2016
12/29/2016 Novel Type of Immunotherapy Helps Man Fight Brain Cancer
12/25/2016 ONC201 Glioblastoma Trial to Expand Based on Promising Initial Results
12/25/2016 Some glioblastoma patients benefit from `ineffective` treatment, Stanford researchers say
12/25/2016 First patient enrolled in brain tumor trial combining 9 repurposed drugs - CUSP9v3 project
12/19/2016 Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
12/13/2016 Medicenna Announces Initiation of Phase 2 Clinical Trial of MDNA55 for the Treatment of Recurrent Glioblastoma
12/13/2016 Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to Israel
12/09/2016 NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer
12/07/2016 Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker Analyses.
12/07/2016 First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites